Navigation Links
CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
Date:10/26/2007

being developed for potential use as a pharmacologic stress agent in myocardial perfusion imaging studies and CVT-6883, which is being developed as a potential treatment for cardiopulmonary diseases. Regadenoson and CVT-6883 have not been determined by any regulatory authorities to be safe or effective in humans for any use.


'/>"/>
SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
3. Sonic Foundry reports GAAP loss as Q2 revenues rise
4. Fiserv reports $113.5 million in Q1 profit
5. Third Wave reports net loss of $18.9M for 2006
6. Musicnotes reports 45 percent growth in 2006
7. Sonic Foundry reports net loss, higher revenue
8. Sonic Foundry reports first cash-positive quarter
9. Merge Healthcare reports $10.8M net loss in Q3
10. Third Wave reports $5.2M third quarter loss
11. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Lionbridge (Nasdaq: LIOX ) today announced ... master services agreement with a multi-billion dollar ... serve patients in approximately 100 countries. With ... provider for translation of the company,s online ... resources, legal, and corporate communications information. Lionbridge ...
(Date:12/14/2009)... Dec. 14 Decision Resources, one of ... pharmaceutical and healthcare issues, finds that, owing to ... fibrillation drug market will increase more than sevenfold ... in 2018 in the United States, France, Germany, ... The new Pharmacor report entitled Atrial Fibrillation ...
(Date:12/14/2009)... -- , - Results From a ... Arthritis in Seven Major Industrialized Countries , , ... say their disease, impacts their ... living with rheumatoid arthritis find shopping for gifts, ... presents most, difficult to do, ...
(Date:12/11/2009)... Corporation (Nasdaq: DNDN ) announced today that ... have exercised in full their option to purchase ... the public offering price of $24.75 per share. ... size of the offering to an aggregate of ... to receive net proceeds from the offering of ...
Breaking Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
... Semiconductor nanowires tiny wires with a diameter as ... hold promise for devices of the future, both in ... transistors and circuits for next generation of electronics. But ... their composition must be precisely controlled, and researchers must ...
... Bulletin Board: TBIO). In a peer-reviewed paper published ... Mutation, a team at Weill Cornell Medical College New ... Transgenomic,s Surveyor Nuclease technology for mutation scanning of ... used in the diagnosis and prognosis of autosomal dominant ...
... US Oncology , the nation,s foremost cancer treatment and ... (USOCD), a full service contract research ... US Oncology Research has provided since ... Oncology Research has offered pharmaceutical and biotechnology companies elements of ...
Other Biology Technology:Researchers peer into nanowires to measure dopant properties 2Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 2Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 3Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology 4US Oncology Provides Full Service Management of Clinical Trials 2US Oncology Provides Full Service Management of Clinical Trials 3
(Date:12/14/2009)... preventing some of the stresses of open surgery on the ... organ dysfunction. Laparoscopy is a type of surgery in the ... By adding another gas to the carbon dioxide used to ... Medical Center have found they can preserve more normal blood ... (ENO) helped to open blood vessels and keep blood flowing, ...
(Date:12/13/2009)... discovered five genetic variants that are associated with the ... international consortium of 96 scientists from 63 centres in ... basis of lung diseases. , The new findings provide ... Obstructive Pulmonary Disease (COPD) and asthma. In the past ... the molecular pathways that affect the health of the ...
(Date:12/11/2009)... FORT COLLINS, COWild Malus orientalis species of wild ... applesare native to the Middle East and Central Asia. ... M. orientalis varieties from Georgia and Armenia ... narrows the large population and establishes a core collection ... to the breeding and research communities. , To identify ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2New genes for lung disease discovered 2Understanding apples' ancestors 2US Farms Inc Receives American Vegetarian Association Certification Approval for Aloe365 28TM 29 Juice Product 62026 1US Farms Inc Receives American Vegetarian Association Certification Approval for Aloe365 28TM 29 Juice Product 62026 2American Scientific Resources Inc Issues Corporate Update 62022 1American Scientific Resources Inc Issues Corporate Update 62022 2American Scientific Resources Inc Issues Corporate Update 62022 3Statement of Support 3A Strengthening Oral Health Care is Key Part of Health Reform 62018 1Statement of Support 3A Strengthening Oral Health Care is Key Part of Health Reform 62018 2
... article in Environmental MicrobiologyAn unusual relationship between bacteria and ... only known partnership (or symbiosis) which uses sunken marine ... the September issue of Environmental Microbiology, Dr Shana Goffredi ... and the Osedax (bone-devouring) group of marine worms. , ...
... global sea-level rise, and the loss of sand dune ... a model to better understand the impacts of development ... grow in the ever-shrinking strip of habitat between land ... William Grant simulated varying levels of sea-level rise to ...
... the risk of developing malignant mesothelioma, according to a study ... to examine the question - will be published this fall ... , Exposure to asbestos in the workplace, particularly in shipyards, ... a rare form of cancer affecting the lining of the ...
Other Biology News:Squeezing out dune plants 2Naturally occurring asbestos linked to lung cancer 2Naturally occurring asbestos linked to lung cancer 3Naturally occurring asbestos linked to lung cancer 4
... to 1 outflow Single-cell and patch delivery ... millisecond) solution change Very small dead volume ... construction 360, 250 and 100 micron delivery ... any micromanipulator Available in 4, 8, and ...
... steadylite plus assay system offers ... sensitivity, Designed for batch-processing systems, ... higher density microplates such as ... free, Convenient storage conditions ( ...
...
... Grace's Insect Medium is formuatled for ... including Sf9 and Sf21 cells. Grace's ... transfectioin because it does not contain ... interfere with transfection. Grace's Insect Medium, ...
Biology Products: